Choice of vincristine or 6-mercaptopurine on the basis of polyamine level in tumor-bearing regions of the brain

Citation
S. Watanabe et al., Choice of vincristine or 6-mercaptopurine on the basis of polyamine level in tumor-bearing regions of the brain, CANCER LETT, 139(1), 1999, pp. 51-58
Citations number
31
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
139
Issue
1
Year of publication
1999
Pages
51 - 58
Database
ISI
SICI code
0304-3835(19990503)139:1<51:COVO6O>2.0.ZU;2-B
Abstract
The effects of vincristine (VC) and 6-mercaptopurine (6-MP) on body weight, regional weights, and the contents of putrescine, spermidine, and spermine in six regions of the brain were examined in rats that had been given thes e drugs for 5 consecutive days. VC is recommended for management of tumors in the corpus striatum and/or hippocampus, and cortex although its efficacy is dependent on the doubling time of the tumor cells, whereas 6-MP is reco mmended for the management of tumors in the cortex, thalamus and/or hypotha lamus, and diencephalon. VC and 6-MI are chosen for treatment of the brain tumors because they reduce polyamines which are associated with the reducti on of drug-sensitive cells and an inhibition of tumor growth. (C) 1999 Else vier Science S.A. All rights reserved.